Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes
- Registration Number
- NCT01145534
- Lead Sponsor
- Federal University of ParaĂba
- Brief Summary
The purpose of this study was to investigate whether the infusion of a medicinal plant (Cissus verticillata L.) would be effective in reducing glucose levels in blood and saliva of type 2 Diabetes patients.
- Detailed Description
Type 2 diabetes mellitus is regarded as one of the most prevalent disease of the adult population. In many developing countries, this condition is regarded as major public health problem. Type 2 diabetes is a metabolic disorder characterized by high blood glucose related with a condition of insulin resistance and relative insulin deficiency. As Diabetes progresses, medications are necessary to control glucose levels.
The aim of this study was to investigate whether the infusion of a medicinal plant (Cissus verticillata L.) would be as effective as a regular drug (glibenclamide) in reducing glucose levels in blood and saliva of type 2 Diabetes patients. Several medicinal plants have been used as potential medication for controlling glucose levels in Diabetes patients. Few studies have explored this effect related to Cissus verticillata L.infusion, though it has been indicated by folk medicine of some Latin American countries.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
- subjects of 30 up to 80 years of age
- positive diagnostic for type 2 diabetes mellitus (blood glucose level above 126 mg/dL)
- patients that signed the informed consent
- patients with renal and hepatic disfunction,
- patients with cardiac problems or other systemic alterations (allergies, pulmonary and gastrointestinal problems)
- pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental medicinal plant infusion Patients ingested the infusion of Cissus verticillata L. prepared as 1 g in 150 mL of hot water for 10 min. This was done daily for 60 days Glibenclamide glibenclamide Patients used 5 mg glibenclamide daily for 60 days
- Primary Outcome Measures
Name Time Method blood glucose 60 days Blood glucose was measured using a Gluco Dr. Plus (AGM-3000) Blood Glucose Monitoring System.
- Secondary Outcome Measures
Name Time Method Salivary glucose level 60 days The level of glucose in saliva was measured in laboratory after colleting non-stimulated saliva in test tubes.
Trial Locations
- Locations (1)
Centro de Especialidades Odontologicas
🇧🇷Patos, Paraiba, Brazil